Journal profile · Immunology
Mediators of Inflammation
ISSN 0962-9351 · eISSN 1466-1861 · John Wiley & Sons, Inc. · USA · Bimonthly · Founded 1992
Mediators of Inflammation: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.85; fully open access; APC about USD 3,340; median 169 days to acceptance (103 articles, last 24 months); community-reported acceptance: about 62.5%; 198 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Mediators of Inflammation is published by John Wiley & Sons, Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Response and Inflammation, Adipokines, Inflammation, and Metabolic Diseases and Asthma and respiratory diseases, together about 25.7% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Mediators of Inflammation is an open access journal that publishes papers on all types of inflammatory mediators, including cytokines, histamine, bradykinin, prostaglandins, leukotrienes, PAF, biological response modifiers and the family of cell adhesion-promoting molecules.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Response and InflammationImmunology and Microbiology11.9%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine7%
- Asthma and respiratory diseasesMedicine6.8%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology6%
- Immune Cell Function and InteractionImmunology and Microbiology5.9%
- Immune cells in cancerImmunology and Microbiology4.9%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience4.9%
- Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunology and Microbiology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.85LetPub ·
- Impact factor (publisher)
- 4.9Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- CiteScore (publisher)
- 8Publisher website ·
- SJR 2026-06
- 1.24LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 78LetPub ·
- h-index
- 176OpenAlex ·
- i10-index
- 4,031OpenAlex ·
- 2-year mean citedness
- 2.48OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 185LetPub ·
Articles by year OpenAlex count · 5,788 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 217 | 217 | 98 |
| 2025 | 198 | 198 | 544 |
| 2024 | 69 | 69 | 556 |
| 2023 | 154 | 154 | 2,291 |
| 2022 | 212 | 212 | 3,929 |
| 2021 | 252 | 252 | 7,309 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
169 daysMedian, submission to acceptance · P25–P75 105 days – 259 days
- Acceptance to online
- median 29 days (103 articles)
- Submission to online
- median 204 days
- Sample
- 103 articles with submission and acceptance dates (409 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 monthsLetPub ·
- Average acceptance (community reports)
- 62.5%LetPub ·
- Acceptance rate (publisher)
- 22%Publisher website ·
- Submission to first decision
- 38 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,340 / GBP 2,230 / EUR 2,890 | Yes | CC BY | |
| OpenAlex | USD 3,040 / EUR 2,630 / GBP 2,230 | — | — | |
| LetPub | USD 2,550 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articlesResearch articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide…Length not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- reviewsA review article provides an overview of the published literature in a particular subject area.Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Concurrent submission limit Model summary
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- License & copyright Copyright and permissions
Copyright policy Model summary
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Open access
Open access journal Model summary
Mediators of Inflammation is an open access journal
Source ↗Publisher website ·- Peer review Peer review
Peer review model Model summary
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Preprints Preprints
Preprint policy Model summary
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons, Inc.
- Country or region
- USA
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1992
- ISSN
- 0962-9351
- Electronic ISSN
- 1466-1861
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Mediators of Inflammation
What CAS zone is Mediators of Inflammation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Mediators of Inflammation is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Mediators of Inflammation?
The latest impact factor listed by LetPub is 4.85; CiteScore 8, h-index 176.
How long does peer review take at Mediators of Inflammation?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 169 days (interquartile range 105–259 days); authors report an average review time of about 4 months; the community-reported acceptance is “about 62.5%”; the journal's website gives an acceptance rate of 22%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Mediators of Inflammation?
According to LetPub and DOAJ records, Mediators of Inflammation is indexed in SCIE, Scopus and DOAJ.
Is Mediators of Inflammation open access, and what is the APC?
Mediators of Inflammation is a fully open-access journal. APC about USD 3,340.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .